Novian Health Raises $11 Million Series A; Ramps Up Studies Of Breast Cancer Laser Ablation

Novian Health Inc. will use its recent $11 million Series A round to kickstart multicenter clinical trials on its Novilase Interstitial Laser Therapy for ablating early-stage breast cancer.